Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04895488
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:56.881759+00:00
Published At
2024-02-26T00:00:00+00:00
Record Updated At
2024-02-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cognitive Impairment With Primary Psychotic Disorder", "Negative Symptoms With Primary Psychotic Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-26"
protocolSection.identificationModule.nctId
"NCT04895488"
protocolSection.identificationModule.officialTitle
"Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cognitive Impairment With Primary Psychotic Disorder (protocolSection.conditionsModule.conditions)
  • Negative Symptoms With Primary Psychotic Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.